Regulators Share Guidance for Effective Sponsor Meetings

Regulators from the U.S. FDA, the U.K. MHRA and other European agencies met to outline best practices for sponsor‑regulator interactions.

They highlighted that transparency, open collaboration, attentive listening, early communication and having enough data to address questions are key to productive meetings.

The advice is intended to help sponsors prepare more effectively and to streamline the regulatory review process.